Residual amount of HBV DNA in serum is related to relapse in chronic hepatitis B patients after cessation of nucleos(t)ide analogs. [electronic resource]
Producer: 20151204Description: 323-8 p. digitalISSN:- 1539-2031
- Adult
- Antiviral Agents -- therapeutic use
- DNA, Viral -- blood
- Female
- Follow-Up Studies
- Hepatitis B virus -- genetics
- Hepatitis B, Chronic -- blood
- Humans
- Male
- Middle Aged
- Nucleotides -- therapeutic use
- Pilot Projects
- Polymerase Chain Reaction
- Recurrence
- Withholding Treatment -- statistics & numerical data
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.